
| Top 5 Drug Type | Count |
|---|---|
| Small molecule drug | 7 |
| Herbal medicine | 2 |
Target |
Mechanism 30S subunit inhibitors [+1] |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. China |
First Approval Date01 Jan 1995 |
Target |
Mechanism DHFR inhibitors [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. China |
First Approval Date01 Jan 1986 |
Target |
Mechanism COX inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. Japan |
First Approval Date22 Aug 1985 |
Start Date15 Jun 2026 |
Sponsor / Collaborator |
Start Date29 Apr 2026 |
Sponsor / Collaborator |
Start Date24 Apr 2026 |
Sponsor / Collaborator |
A novel aromatic polyamide (PA) reverse osmosis membrane with nanoscale water channels and hydrophilic molecular skin surface, similar to those of biomimetic neural networks, was realized for textile wastewater treatment
Polyamide aromatic (PA) reverse osmosis (RO) membranes are currently the most important materials in the seawater desalination and wastewater treatment industry.

| Drug(Targets) | Indications | Global Highest Phase |
|---|---|---|
Oxaprozin ( COXs ) | Pain More | Approved |
Ergocalciferol ( VDR ) | Rickets More | Approved |
KangFuXiaoYan | Pelvic Inflammatory Disease More | Approved |
Probenecid ( OAT1 ) | Gout More | Approved |
Gentamicin Sulfate/Trimethoprim ( 30S subunit x DHFR ) | Infectious Diseases More | Approved |





